ESROKAST-A Tablets combine the powerful benefits of Levocetirizine Dihydrochloride, Montelukast Sodium, and Ambroxol Hydrochloride (Sustained Release) to provide comprehensive relief from respiratory allergies, asthma, and mucus-related breathing difficulties. This triple-action formulation helps reduce allergic symptoms, relax the airways, and clear mucus from the respiratory tract.
Form: Film-coated tablet
Composition (per tablet):
Levocetirizine Dihydrochloride IP – 5 mg
Montelukast Sodium IP – 10 mg (assuming Pontridust is Montelukast; correcting typo)
Ambroxol Hydrochloride IP (Sustained Release) – 75 mg
Colour: Yellow oxide & Titanium Dioxide
Pack Size: 10 × 10 Tablets
MRP: ₹149/-
✔ Triple-Action Formula – Combats allergies, asthma, and mucus congestion
✔ Antihistamine Power – Levocetirizine helps relieve sneezing, itching, and watery eyes
✔ Anti-Inflammatory Support – Montelukast reduces airway inflammation and prevents asthma attacks
✔ Mucolytic Effect – Ambroxol SR helps break down and clear mucus for easier breathing
✔ Sustained Release Advantage – Long-lasting symptom relief throughout the day
Why Choose ESROKAST-A?
This unique 3-in-1 respiratory care solution addresses the root causes of breathing problems, not just the symptoms. It is ideal for patients suffering from chronic allergies, asthma, or bronchitis with excessive mucus production.
